EX-10.1







Exhibit 10.1




			
	 	 	 
	
	 	UBS Financial Services Inc.               






Please
complete and sign this form. 
We must receive it by November 14, 2008.




Acceptance
of UBS’s offer relating to auction rate securities.

By signing below and returning this form, I accept UBS’s offer of Rights relating to my
Eligible ARS in the account listed below. I understand and acknowledge the following:





	•	 	All Eligible ARS must remain in my UBS account listed below until I exercise my Rights
to sell my Eligible ARS to UBS or
they are redeemed by the issuer or purchased or sold on my behalf by UBS;
	 
	•	 	I will instruct my UBS Financial Advisor or Branch Manager if and when I want to
exercise my Rights and sell my Eligible
ARS to UBS during the period of June 30, 2010, through July 2, 2012;
	 
	•	 	The acceptance of UBS’s offer constitutes consent (to the extent legally required) for
UBS, acting as principal, to purchase
my Eligible ARS or to sell them on my behalf at any time in its sole discretion and without
other prior notice to me, from

the date that I accept this offer through July 2, 2012;
	 
	•	 	If UBS purchases, sells or otherwise disposes of my Eligible ARS, it will deposit
the par value in my account within one
business day of settlement of the transaction;
	 
	•	 	I release UBS and its employees/agents from all claims except claims for consequential
damages directly or indirectly relating
to its marketing and sale of ARS and expressly agree that I will not seek any damages or
costs (punitive damages, attorney
fees, etc.) other than consequential damages. I also will not serve as a class
representative or receive benefits under any
class action settlement or investor fund;
	 
	•	 	If the account named below is in the name of a corporation, partnership, trust or other
entity, I represent and warrant that I
have the power and authority to accept this offer on behalf of that entity.







  

CARDIOVASCULAR SYSTEMS, INC.

651 CAMPUS DRIVE

ST. PAUL MN 55112-3495
 
 
 
 

Account



Number: CP 03041







Please complete and sign this form.

We must receive it by November 14, 2008.




	 	 	 
	Mail

	 	UBS Financial Services Inc.
	 

	 	ATTN: ARS Group
	 

	 	1000 Harbor Boulevard
	 

	 	Weehawken, NJ 07086
	 
	 	 
	Fax

	 	+1-201-442-7766











	 	 	 	 	 	 	 	 	 	 	 
	Account owner signature

	 	/s/ James Flaherty 	 	 	 	Date
	 	11/7/08	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Additional party signature

	 	/s/ Michael J. Kallok	 	 	 	Date
	 	11/7/2008	 	 
	 

	 	 

	 	 	 	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Daytime telephone number

	 	651-259-1611	 	 	 	 	 	 	 	 
	 

	 	 

	 	 	 	 	 	 	 	 





If you have questions, please contact your UBS Financial Advisor or Branch Manager
at +1-312-525-4500. 
Clients outside the U.S. may call +1-201-352-0105 collect.



We kindly request that you do not include comments or questions on this form as it could delay
processing of your instructions.



UBS AG has filed a registration statement (including a prospectus) with the SEC for the
offering to which this communication relates. Before you make an investment decision, you
should read the prospectus in that registration statement and other documents that UBS has
filed with the SEC for more complete information about UBS and this offering. You may get
these documents for free by visiting EDGAR on the SEC Web site at
www.sec.gov or by calling
UBS’s ARS Client Service Center at +1-800-253-1974.



UBS Financial Services Inc. serves as the clearing firm for UBS International Inc.
Accordingly, the information and terms contained in this letter and the accompanying materials
are directed to clients of both UBS Financial Services Inc and UBS International Inc.




			
	 	 	 
	©2008 UBS Financial Services Inc. All rights reserved. Member SIPC.
	 	1C-ARSO











000336